ACCESS Newswire
04 Feb 2023, 01:01 GMT+10
SAN FRANCISCO, CA / AACCESSWIRE / February 3, 2023 / Hagens Berman urges Fate Therapeutics, Inc. (NASDAQ:FATE) investors who suffered significant losses to submit your losses now.
Class Period: Apr. 2, 2020 - Jan. 5, 2023
Lead Plaintiff Deadline: Mar. 22, 2023
Visit: https://www.hbsslaw.com/investor-fraud/FATE
Contact An Attorney Now: [email protected]
844-916-0895
Fate Therapeutics, Inc. (FATE) Securities Fraud Class Action:
The litigation focuses on Fate's widely touted April 2020 collaboration agreement with Janssen Biotech, pursuant to which Janssen and Fate agreed to collaborate to develop iPSC-derived CAR-NK and CAR T-cell product candidates for the treatment of cancer. Under this agreement, Fate received a $50 million up front payment and was eligible to receive up to $3 billion in various milestone payments and royalties.
According to the complaint, Defendants made materially misleading statements and failed to disclose that: (1) the Janssen agreement was less sustainable than Fate represented to investors; (2) accordingly, certain clinical programs, milestone payments, and royalty payments associated with the agreement could not be relied upon as future revenue sources; and (3) as a result, Fate overstated the impact of the Janssen agreement on Fate's long-term clinical and commercial profitability.
The truth emerged on Jan. 5, 2023, when Fate announced that it terminated the Janssen collaboration agreement after Fate declined Janssen's proposal to continue the agreement on revised terms. The company also said that all collaboration activities with Janssen will be wound down during Q1 2023 and that it is slashing its workforce from 545 (as of Sept. 30, 2022) to about 220 in Q1 2023.
This news resulted in a wave of analyst downgrades and drove the price of Fate Therapeutics shares down over 60% in a single day.
'We're focused on investors' losses and proving Fate misled investors about the strength of- and prospects for- its work with Janssen,' said Reed Kathrein, the Hagens Berman partner leading the investigation.
If you invested in Fate Therapeutics and have significant losses, or have knowledge that may assist the firm's investigation, click here to discuss your legal rights with Hagens Berman.
Whistleblowers: Persons with non-public information regarding Fate Therapeutics should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email [email protected].
# # #
About Hagens Berman
Hagens Berman is a global plaintiffs' rights complex litigation law firm focusing on corporate accountability through class-action law. The firm is home to a robust securities litigation practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and fraud. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw.
Contact:
Reed Kathrein, 844-916-0895
SOURCE: Hagens Berman Sobol Shapiro LLP
Get a daily dose of Raleigh Times news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Raleigh Times.
More InformationMILAN, Italy: Italian regulators have flagged four non-EU countries—including Russia—as carrying systemic financial risk for domestic...
NEW YORK CITY, New York: With just weeks to spare before a potential government default, U.S. lawmakers passed a sweeping tax and spending...
PARIS, France: Fast-fashion giant Shein has been fined 40 million euros by France's antitrust authority over deceptive discount practices...
PALO ALTO/TEL AVIV: The battle for top AI talent has claimed another high-profile casualty—this time at Safe Superintelligence (SSI),...
FRANKLIN, Tennessee: Hundreds of thousands of Nissan and Infiniti vehicles are being recalled across the United States due to a potential...
REDMOND, Washington: Microsoft is the latest tech giant to announce significant job cuts, as the financial strain of building next-generation...
WASHINGTON, D.C.: In a significant ruling last week, the U.S. Supreme Court upheld a Texas law requiring age verification for users...
Birmingham [UK], July 7 (ANI): After England's heavy 336-run defeat to India, captain Ben Stokes hinted at the possibility of Jofra...
The virus was likely first developed at the University of North Carolina, the analyst claims Covid-19 was almost certainly developed...
(Photo credit: Kirby Lee-Imagn Images) Sacramento State head coach Brennan Marion reached into Southeastern Conference territory...
(Photo credit: Stephen Brashear-Imagn Images) Dan Wilson and Ken Griffey Jr. were teammates when the latter hit a franchise-record...
(Photo credit: Kamil Krzaczynski-Imagn Images) The Chicago Cubs set a franchise record by bashing eight home runs in a single game...